Showing results (61-70 of 110) with videos related to
Sort By:
Pageof 11
Computers and Biomedical Research, an International Journal|August 1, 1986
Evaluation of scintigraphic data of renal transplantsP Schmidlin, J H Clorius, E M Lubosch, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 12, 2013
[Intracavernous injection: a treatment modality for erectile dysfunction]E Uche-Holub, U Thierling, M Giessing, et al.Der Urologe. Ausg. A|December 6, 2005
[Modern immunosuppression following renal transplantation. Standard or tailor made?]K Budde, M Giessing, L Liefeldt, et al.Transplantation Proceedings|September 25, 2007
Kidney transplantation in children and adolescentsM Giessing, D Muller, B Winkelmann, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1980
Posture-induced disturbance of pertechnetate flow and I-123 iodohippurate transport in some renal graft recipients with hypertensionJ H Clorius, K Dreikorn, J Zelt, et al.Clinical Genetics|June 14, 2000
Gender-specific effects of NAT2 and GSTM1 in bladder cancerE Schnakenberg, M Lustig, R Breuer, et al.International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Technetium-99m labeled renal function and imaging agents: I. Clinical evaluation of 99mTc CO2-DADS-A (99mTc N,N'-bis-(mercaptoacetyl)-2,3-diaminopropanoate)B Bubeck, W Brandau, F Reinbold, et al.Hepato-Gastroenterology|August 1, 1988
HBV DNA and other hepatitis B virus markers in sera from long-term hemodialysis and kidney transplant patientsL Theilmann, K Gmelin, M Rambausek, et al.Clinical Genetics|July 11, 1998
Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patientsE Schnakenberg, C Ehlers, W Feyerabend, et al.European Journal of Nuclear Medicine|January 1, 1985
Renal perfusion and mean vascular transit timeP Schmidlin, J H Clorius, E M Lubosch, et al.Pageof 11